COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study.

ABSTRACT:

Background

The global COVID-19 pandemic disproportionately affected certain populations and its management differed between countries. This national study describes characteristics and outcomes of COVID-19 in patients with cancer in Australia.

Methods

We performed a multicentre cohort study of patients with cancer and COVID-19 from March 2020 to April 2022. Data were analysed to determine varying characteristics between cancer types and changes in outcomes over time. Multivariable analysis was performed to determine risk factors associated with oxygen requirement.

Findings

620 patients with cancer from 15 hospitals had confirmed COVID-19. There were 314/620 (50.6%) male patients, median age 63.5 years (IQR 50-72) and majority had solid organ tumours (392/620, 63.2%).

SUBMITTER: Hall VG 

PROVIDER: S-EPMC10278158 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature